Skip to content
★ Sign in to follow
MS

Mina Sooch

Présidente-Directrice Générale
Total declarations
13
Companies
3
▲ Purchases (4 ops.)
€518k
▼ Sales (0 ops.)
—

Latest filing published 12 Jan 2023 for Ocuphire Pharma, Inc..

Filing timeline

BuySale
Mina Sooch

Insider track record

Disclosed buys
4
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Mina Sooch: trading record in brief

This profile gathers the share dealings of Mina Sooch across 3 companies, led by Opus Genetics, Inc., MetaVia Inc. and Biovie Inc. Over a trading history stretching from 10 August 2016 to 10 January 2023, the count stands at 13 filings.

On the market, this insider has only ever bought: 4 purchases, €518k in total. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants.

The median purchase comes to €24k. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 12 January 2023 with a share grant in Opus Genetics, Inc. The clock since the last published purchase (23 May 2022) now reads 1,631 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Mina Sooch

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ◆
    President and CEOExecutivesOcuphire Pharma, Inc.
    0SEC
    134,456 shares0Common StockSEC:0001140361-23-001520:0
  • ◆
    President and CEOExecutivesOcuphire Pharma, Inc.
    0 USD28SEC
    1,023 shares@ US$0.00010.0% of flowCommon StockSEC:0001140361-22-032758:0
  • ▲
    President and CEOExecutivesOcuphire Pharma, Inc.
    25,879 USD34SEC
    12,500 shares@ US$2.0703100.0% of flowCommon StockSEC:0001140361-22-020274:0
    Canonical exit: 17 Aug 2022 (T+90)

3 of 3 declarations